Compile Data Set for Download or QSAR
Report error Found 24 Enz. Inhib. hit(s) with all data for entry = 9526
TargetIntegrin alpha-V/beta-1(Human)
University of California

US Patent
LigandPNGBDBM472699(US10836720, HIJ-1483)
Affinity DataIC50: 100nMAssay Description:The blockade of integrin alpha 5 beta 1 provides a novel target for the treatment of asthma. As shown in FIGS. 1A and 1B, delivery of ATN-161, a low ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
Go to US Patent

TargetIntegrin alpha-V/beta-1(Human)
University of California

US Patent
LigandPNGBDBM472679(US10836720, HIJ-1017)
Affinity DataIC50: 100nMAssay Description:The blockade of integrin alpha 5 beta 1 provides a novel target for the treatment of asthma. As shown in FIGS. 1A and 1B, delivery of ATN-161, a low ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
Go to US Patent

TargetIntegrin alpha-V/beta-1(Human)
University of California

US Patent
LigandPNGBDBM472698(US10836720, HIJ-1437)
Affinity DataIC50: 100nMAssay Description:The blockade of integrin alpha 5 beta 1 provides a novel target for the treatment of asthma. As shown in FIGS. 1A and 1B, delivery of ATN-161, a low ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
Go to US Patent

TargetIntegrin alpha-V/beta-1(Human)
University of California

US Patent
LigandPNGBDBM472684(US10836720, HIJ-1018)
Affinity DataIC50: 100nMAssay Description:The blockade of integrin alpha 5 beta 1 provides a novel target for the treatment of asthma. As shown in FIGS. 1A and 1B, delivery of ATN-161, a low ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
Go to US Patent

TargetIntegrin alpha-V/beta-1(Human)
University of California

US Patent
LigandPNGBDBM472692(US10836720, HIJ-1204)
Affinity DataIC50: 100nMAssay Description:The blockade of integrin alpha 5 beta 1 provides a novel target for the treatment of asthma. As shown in FIGS. 1A and 1B, delivery of ATN-161, a low ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
Go to US Patent

TargetIntegrin alpha-V/beta-1(Human)
University of California

US Patent
LigandPNGBDBM472690(US10836720, HIJ-1099)
Affinity DataIC50: 100nMAssay Description:The blockade of integrin alpha 5 beta 1 provides a novel target for the treatment of asthma. As shown in FIGS. 1A and 1B, delivery of ATN-161, a low ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
Go to US Patent

TargetIntegrin alpha-V/beta-1(Human)
University of California

US Patent
LigandPNGBDBM472676(US10836720, HIJ-1016)
Affinity DataIC50: 100nMAssay Description:The blockade of integrin alpha 5 beta 1 provides a novel target for the treatment of asthma. As shown in FIGS. 1A and 1B, delivery of ATN-161, a low ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
Go to US Patent

TargetIntegrin alpha-V/beta-1(Human)
University of California

US Patent
LigandPNGBDBM472689(US10836720, HIJ-1094)
Affinity DataIC50: 100nMAssay Description:The blockade of integrin alpha 5 beta 1 provides a novel target for the treatment of asthma. As shown in FIGS. 1A and 1B, delivery of ATN-161, a low ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
Go to US Patent

TargetIntegrin alpha-V/beta-1(Human)
University of California

US Patent
LigandPNGBDBM472689(US10836720, HIJ-1094)
Affinity DataIC50: 100nMAssay Description:The blockade of integrin alpha 5 beta 1 provides a novel target for the treatment of asthma. As shown in FIGS. 1A and 1B, delivery of ATN-161, a low ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
Go to US Patent

TargetIntegrin alpha-V/beta-1(Human)
University of California

US Patent
LigandPNGBDBM472690(US10836720, HIJ-1099)
Affinity DataIC50: 5.05E+3nMAssay Description:The blockade of integrin alpha 5 beta 1 provides a novel target for the treatment of asthma. As shown in FIGS. 1A and 1B, delivery of ATN-161, a low ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
Go to US Patent

TargetIntegrin alpha-V/beta-1(Human)
University of California

US Patent
LigandPNGBDBM472687(US10836720, HIJ-1093)
Affinity DataIC50: 5.05E+3nMAssay Description:The blockade of integrin alpha 5 beta 1 provides a novel target for the treatment of asthma. As shown in FIGS. 1A and 1B, delivery of ATN-161, a low ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
Go to US Patent

TargetIntegrin alpha-V/beta-1(Human)
University of California

US Patent
LigandPNGBDBM472687(US10836720, HIJ-1093)
Affinity DataIC50: 5.05E+3nMAssay Description:The blockade of integrin alpha 5 beta 1 provides a novel target for the treatment of asthma. As shown in FIGS. 1A and 1B, delivery of ATN-161, a low ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
Go to US Patent

TargetIntegrin alpha-V/beta-1(Human)
University of California

US Patent
LigandPNGBDBM472686(US10836720, HIJ-1083)
Affinity DataIC50: 5.05E+3nMAssay Description:The blockade of integrin alpha 5 beta 1 provides a novel target for the treatment of asthma. As shown in FIGS. 1A and 1B, delivery of ATN-161, a low ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
Go to US Patent

TargetIntegrin alpha-V/beta-1(Human)
University of California

US Patent
LigandPNGBDBM472686(US10836720, HIJ-1083)
Affinity DataIC50: 5.05E+3nMAssay Description:The blockade of integrin alpha 5 beta 1 provides a novel target for the treatment of asthma. As shown in FIGS. 1A and 1B, delivery of ATN-161, a low ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
Go to US Patent

TargetIntegrin alpha-V/beta-1(Human)
University of California

US Patent
LigandPNGBDBM472684(US10836720, HIJ-1018)
Affinity DataIC50: 5.05E+3nMAssay Description:The blockade of integrin alpha 5 beta 1 provides a novel target for the treatment of asthma. As shown in FIGS. 1A and 1B, delivery of ATN-161, a low ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
Go to US Patent

TargetIntegrin alpha-V/beta-1(Human)
University of California

US Patent
LigandPNGBDBM472679(US10836720, HIJ-1017)
Affinity DataIC50: 5.05E+3nMAssay Description:The blockade of integrin alpha 5 beta 1 provides a novel target for the treatment of asthma. As shown in FIGS. 1A and 1B, delivery of ATN-161, a low ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
Go to US Patent

TargetIntegrin alpha-V/beta-1(Human)
University of California

US Patent
LigandPNGBDBM472676(US10836720, HIJ-1016)
Affinity DataIC50: 5.05E+3nMAssay Description:The blockade of integrin alpha 5 beta 1 provides a novel target for the treatment of asthma. As shown in FIGS. 1A and 1B, delivery of ATN-161, a low ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
Go to US Patent

TargetIntegrin alpha-V/beta-1(Human)
University of California

US Patent
LigandPNGBDBM472691(US10836720, HIJ-1203)
Affinity DataIC50: 1.00E+4nMAssay Description:The blockade of integrin alpha 5 beta 1 provides a novel target for the treatment of asthma. As shown in FIGS. 1A and 1B, delivery of ATN-161, a low ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
Go to US Patent

TargetIntegrin alpha-V/beta-1(Human)
University of California

US Patent
LigandPNGBDBM472691(US10836720, HIJ-1203)
Affinity DataIC50: 1.00E+4nMAssay Description:The blockade of integrin alpha 5 beta 1 provides a novel target for the treatment of asthma. As shown in FIGS. 1A and 1B, delivery of ATN-161, a low ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
Go to US Patent

TargetIntegrin alpha-V/beta-1(Human)
University of California

US Patent
LigandPNGBDBM472692(US10836720, HIJ-1204)
Affinity DataIC50: 1.00E+4nMAssay Description:The blockade of integrin alpha 5 beta 1 provides a novel target for the treatment of asthma. As shown in FIGS. 1A and 1B, delivery of ATN-161, a low ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
Go to US Patent

TargetIntegrin alpha-V/beta-1(Human)
University of California

US Patent
LigandPNGBDBM472694(US10836720, HIJ-1213)
Affinity DataIC50: 1.00E+4nMAssay Description:The blockade of integrin alpha 5 beta 1 provides a novel target for the treatment of asthma. As shown in FIGS. 1A and 1B, delivery of ATN-161, a low ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
Go to US Patent

TargetIntegrin alpha-V/beta-1(Human)
University of California

US Patent
LigandPNGBDBM472694(US10836720, HIJ-1213)
Affinity DataIC50: 1.00E+4nMAssay Description:The blockade of integrin alpha 5 beta 1 provides a novel target for the treatment of asthma. As shown in FIGS. 1A and 1B, delivery of ATN-161, a low ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
Go to US Patent

TargetIntegrin alpha-V/beta-1(Human)
University of California

US Patent
LigandPNGBDBM472695(US10836720, HIJ-1216)
Affinity DataIC50: 1.00E+4nMAssay Description:The blockade of integrin alpha 5 beta 1 provides a novel target for the treatment of asthma. As shown in FIGS. 1A and 1B, delivery of ATN-161, a low ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
Go to US Patent

TargetIntegrin alpha-V/beta-1(Human)
University of California

US Patent
LigandPNGBDBM472695(US10836720, HIJ-1216)
Affinity DataIC50: 1.00E+4nMAssay Description:The blockade of integrin alpha 5 beta 1 provides a novel target for the treatment of asthma. As shown in FIGS. 1A and 1B, delivery of ATN-161, a low ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
Go to US Patent